Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
2.040
+0.170 (9.09%)
At close: Nov 9, 2026, 4:00 PM EST
2.050
+0.010 (0.49%)
Pre-market: Nov 10, 2026, 4:59 AM EST
Foghorn Therapeutics Employees
Foghorn Therapeutics had 106 employees as of December 31, 2025. The number of employees decreased by 6 or 5.36% compared to the previous year. That makes Foghorn Therapeutics the 31,066th largest employer in the world and 3,961st in the United States.
Employees
106
Change (1Y)
-6
Growth (1Y)
-5.36%
Revenue / Employee
$1,057,821
Profits / Employee
$88,868
Market Cap
122.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -6 | -5.36% |
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Immunic | 100 |
| enGene Therapeutics | 82 |
| OnKure Therapeutics | 45 |
| LENZ Therapeutics | 40 |
| Milestone Pharmaceuticals | 38 |
| Anavex Life Sciences | 34 |
| NovaBridge Biosciences | 30 |
FHTX News
- 21 hours ago - Foghorn Therapeutics reports Q3 EPS 80c, consensus (25c) - TheFly
- 22 hours ago - Foghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update - GlobeNewsWire
- 22 hours ago - Foghorn Therapeutics Quarterly report: Q3 2026 - Filings
- 22 hours ago - Foghorn Therapeutics Earnings release: Q3 2026 - Filings
- 6 days ago - Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - GlobeNewsWire
- 4 weeks ago - Foghorn Therapeutics downgraded to In Line from Outperform at Evercore ISI - TheFly
- 4 weeks ago - FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law - Business Wire
- 5 weeks ago - Wedbush downgrades Foghorn on end of Lilly collaboration - TheFly